New NK1 antagonists with excellent in vitro and in vivo profile designed at Merck & Co. Dec. 14, 1998
Ebastine reported at World Asthma Meeting to have potential in allergic inflammatory conditions Dec. 11, 1998
Effects of calcium sensitization modulator Y-27632 on human bronchial tissues and pulmonary artery Dec. 11, 1998
SB-207499: confirmation of PDE4 inhibition as a novel approach to respiratory disorders Dec. 11, 1998
Targeted Genetics initiates phase I trials of aerosolized gene therapy for treatment of CF Dec. 11, 1998
RSS